Table 4. Isolates from blood cultures (n = 1212).
Isolate from blood culture | Number of positive cultures |
S. enterica Typhi | 22a (1.8%) |
S. pneumoniae | 13b (1.1%) |
E. coli | 8c (0.7%) |
H. influenzae | 7 (0.6%) |
B. pseudomallei | 6e (0.5%) |
S. aureus | 6d (0.5%) |
K. pneumoniae | 4f (0.3%) |
Acinetobacter baumannii | 3 (0.2%) |
N. meningitidis | 2 (0.2%) |
S. pyogenes | 2 (0.2%) |
Yeast | 1 (<0.1%) |
Pantoea spp. | 1 (<0.1%) |
P. aeruginosa | 1 (<0.1%) |
Total true isolates | 76 (6.3%) |
Isolates of uncertain significance | |
Unidentified Gram-negative bacilli | 5 (0.4%) |
Pseudomonas spp. | 5 (0.4%) |
Acinetobacter calcoaceticus | 4 (0.3%) |
Ochrobactum anthropi | 3 (0.2%) |
Burkholderia cepacia | 2 (0.2%) |
Moraxella spp. | 2 (0.2%) |
Alcaligenes faecalis | 1 (0.1%) |
Gemella morbillorum | 1 (0.1%) |
Sphingobacterium spiritivorum | 1 (0.1%) |
Stenotrophomonas maltophilia | 1 (0.1%) |
Streptococcus sanguinis | 1 (0.1%) |
Total isolates of uncertain significance | 26 (2.1%) |
Contaminants | 60g (5.0%) |
19/21 (90.5%) had intermediate susceptibility to ciprofloxacin; 18/21 (85.7%) were multi-drug resistant (resistant to chloramphenicol, ampicillin and co-trimoxozole).
8 strains were available for testing, all were susceptible to ceftriaxone.
4 strains were available for testing, one was ESBL producing.
6 strains available for testing, one was MRSA.
Constitutively resistant to ceftriaxone.
2 strains available for testing, one was ESBL producing.
33 coagulase-negative staphylococci, 27 Gram-positive bacilli.